Founders Capital Management (Texas)’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.96M | Buy |
38,583
+1,831
| +5% | +$214K | 2.15% | 18 |
|
|
2026
Q1 | $4.42M | Buy |
36,752
+776
| +2% | +$89.6K | 2.16% | 18 |
|
|
2025
Q4 | $3.79M | Sell |
35,976
-551
| -2% | -$51.7K | 1.97% | 16 |
|
|
2025
Q3 | $3.07M | Sell |
36,527
-408
| -1% | -$33.6K | 1.62% | 18 |
|
|
2025
Q2 | $2.92M | Buy |
36,935
+94
| +0.3% | +$7.47K | 1.75% | 19 |
|
|
2025
Q1 | $3.31M | Sell |
36,841
-6,979
| -16% | -$652K | 2.14% | 15 |
|
|
2024
Q4 | $4.36M | Sell |
43,820
-1,462
| -3% | -$151K | 2.76% | 16 |
|
|
2024
Q3 | $5.14M | Buy |
45,282
+728
| +2% | +$86.5K | 3.13% | 15 |
|
|
2024
Q2 | $5.52M | Sell |
44,554
-371
| -0.8% | -$47.8K | 3.57% | 12 |
|
|
2024
Q1 | $5.93M | Sell |
44,925
-567
| -1% | -$69.9K | 4.01% | 8 |
|
|
2023
Q4 | $4.96M | Sell |
45,492
-256
| -0.6% | -$26.6K | 3.6% | 8 |
|
|
2023
Q3 | $4.71M | Sell |
45,748
-271
| -0.6% | -$29.2K | 3.6% | 8 |
|
|
2023
Q2 | $5.31M | Sell |
46,019
-609
| -1% | -$69.1K | 3.86% | 7 |
|
|
2023
Q1 | $4.96M | Sell |
46,628
-290
| -0.6% | -$31.3K | 3.79% | 7 |
|
|
2022
Q4 | $5.21M | Buy |
46,918
+1
| +0% | +$102 | 3.91% | 7 |
|
|
2022
Q3 | $4.04M | Sell |
46,917
-344
| -0.7% | -$30.7K | 3.3% | 8 |
|
|
2022
Q2 | $4.31M | Buy |
47,261
+22,494
| +91% | +$1.99M | 3.4% | 8 |
|
|
2022
Q1 | $1.9M | Hold |
24,767
| – | – | 1.22% | 27 |
|
|
2021
Q4 | $1.9M | Sell |
24,767
-598
| -2% | -$47.6K | 1.22% | 27 |
|
|
2021
Q3 | $1.91M | Sell |
25,365
-2,075
| -8% | -$158K | 1.31% | 26 |
|
|
2021
Q2 | $2.13M | Sell |
27,440
-809
| -3% | -$60.2K | 1.39% | 26 |
|
|
2021
Q1 | $2.08M | Sell |
28,249
-52
| -0.2% | -$3.84K | 1.48% | 26 |
|
|
2020
Q4 | $2.21M | Buy |
+28,301
| New | +$2.16M | 1.56% | 26 |
|
|
2020
Q1 | $2.32M | Sell |
31,608
-1,215
| -4% | -$95.5K | 2.41% | 17 |
|
|
2019
Q4 | $2.85M | Buy |
32,823
+5,114
| +18% | +$420K | 2.16% | 20 |
|
|
2019
Q3 | $2.23M | Buy |
27,709
+13,440
| +94% | +$1.08M | 1.78% | 25 |
|
|
2019
Q2 | $1.14M | Hold |
14,269
| – | – | 1.01% | 28 |
|
|
2019
Q1 | $1.13M | Hold |
14,269
| – | – | 1.06% | 26 |
|
|
2018
Q4 | $1.04M | Sell |
14,269
-78
| -0.5% | -$5.51K | 1.11% | 28 |
|
|
2018
Q3 | $971K | Hold |
14,347
| – | – | 0.8% | 35 |
|
|
2018
Q2 | $831K | Buy |
14,347
+1,521
| +12% | +$85.8K | 0.73% | 37 |
|
|
2018
Q1 | $667K | Buy |
12,826
+78
| +0.6% | +$4.21K | 0.56% | 42 |
|
|
2017
Q4 | $684K | Hold |
12,748
| – | – | 0.57% | 44 |
|
|
2017
Q3 | $779K | Sell |
12,748
-105
| -0.8% | -$6.37K | 0.65% | 45 |
|
|
2017
Q2 | $786K | Sell |
12,853
-1,519
| -11% | -$92.5K | 0.7% | 44 |
|
|
2017
Q1 | $871K | Buy |
+14,372
| New | +$872K | 0.78% | 41 |
|
Other funds holding MRK
LMFP
ATO
QP
Founders Capital Management (Texas)'s MRK Position: Q2 2026 in Review
Founders Capital Management (Texas) increased its Merck (MRK) stake by 5% in Q2 2026, buying an estimated $214K and bringing the position to 38,583 shares worth $4.96M. The position accounts for 2.15% of the portfolio, ranked #18.
Founders Capital Management (Texas) first reported a position in MRK in Q1 2017 and has held it in 36 quarters since. The position peaked at $5.93M in Q1 2024. 1,207 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Founders Capital Management (Texas) held 38,583 shares of Merck worth $4.96M as of Q2 2026.
- Founders Capital Management (Texas) bought 1,831 Merck shares in Q2 2026, an estimated $214K.
- Merck made up 2.15% of Founders Capital Management (Texas)'s portfolio in Q2 2026, its #18 holding.
- Founders Capital Management (Texas) first reported a position in Merck in Q1 2017 and has held it in 36 quarters since.
- Founders Capital Management (Texas)'s Merck position peaked at $5.93M in Q1 2024.
- 1,207 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Founders Capital Management (Texas)'s 13F filing for Q2 2026, filed 21 Jul 2026.